Groll, AH, Walsh, TJ. Uncommon opportunistic fungi: new nosocomial threats. European Journal of Clinical Microbiology and Infectious Diseases
2001; 7: 8–24.
Haron, E, et al.
Primary Candida pneumonia. Experience at a large cancer center and review of literature. Medicine (Baltimore)
1993; 72: 137–142.
Gill, PK, Gill, JS.
Blastoschizomyces capitatus pneumonia in an immunocompetent female. Indian Journal of Tuberculosis
2011; 58: 88–89.
Sreeja, S, et al.
Blastoschizomyces capitatus pneumonia: a rare case. Indian Journal of Pathology and Microbiology
2011; 54: 846–847.
Dhevahi, E, et al.
Blastoschizomyces capitatus an rare opportunistic infection alerts the clinical correlation from a territory care hospital at Chennai. Journal of Dental and Medical Sciences
2014; 13: 59–62.
Chauhan, S, et al.
Pulmonary infection by Blastoschizomyces capitatus in an old tuberculosis patient. Journal of Clinical and Diagnostic Research
2015; 9: 1–2.
Wills, TS, et al.
Blastoschizomyces capitatus pneumonia in an immunocompetent male. Southern Medical Journal
2004; 97: 702–704.
Blastoschizomyces capitatus infection in an immunocompetent man. Journal of Respiratory Diseases
2007; 28: 82.
Subramanya Supram, H, et al.
Emergence of Magnusiomyces capitatus infections in Western Nepal. Medical Mycology
2016; 54: 103–110.
Pesut, D, et al.
Bilateral pulmonary shadows and incapsulated mediastinal effusion in a patient with respiratory blastoschizomycosis. Pneumonologia
2008; 57: 88–91.
Miglietta, F, et al.
A rare case of Saprochaete capitata fungemia in a critical ill patient without hematologic and oncological disorders. Revista Espanola de Quimioterapia
2016; 29: 47–49.
Brunetti, G, et al.
Management and treatment of Magnusiomyces capitatum (Geotrichum capitatum) pleural infection in a non-neutropenic patient with posaconazole. A new therapeutic opportunity?
The New Microbiologica
2016; 39: 307–309.
Pfaller, MA, Diekema, DJ, Merz, WG. Infections caused by non-Candida, non-Cryptococcal yeasts. Clinical Mycology
2009; 2: 261.
Arendrup, MC, et al.
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. European Society of Clinical Microbiology and Infectious Diseases
2013; 20: 76–98.
Prodhan, T, et al.
Non Candida yeast fungemia in cancer patients: a retrospective analysis at a referral cancer center, 1999–2014. Infectious Diseases in Clinical Practice
2015; 23: 260–262.
Martino, P, et al.
Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Reviews of Infectious Diseases
1990; 15: 570–582.
Malani, AN, Kauffman, CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs
2007; 67: 1803–1812.
Fasciana, T, et al.
Genotyping and antifungal susceptibility of Dipodascus capitatus isolated in a neonatal intensive care unit of a Sicilian hospital. Advances in Experimental Medicine and Biology
2017; 973: 81–88.
Chitasombat, MN, et al.
Rare opportunistics (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. Journal of Infection
2012; 64: 68–75.
Girmenia, C, et al.
GIMEMA Infection Program. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. Journal of Clinical Microbiology
2005; 43: 1818–1828.
Mathews, MS, Sudipta, S.
Blastoschizomyces capitatus infection after contamination of fluids for intravenous application. Mycoses
1998; 41: 427–428.
Gurgui, M, et al.
Nosocomial outbreak of Blastoschizomyces capitatus associated with contaminated milk in a haematological unit. Journal of Hospital Infection
2011; 78: 274–278.
Salkin, IF, et al.
Blastoschizomyces capitatus, a new combination. Mycotaxon
1986; 22: 375–380.
Bouza, E, Munoz, P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clinical Microbiology and Infection
2004; 10: 76–85.
Pontieri, E, et al.
Genetic variability among Blastoschizomyces capitatus isolates from different clinical sources. International Journal of Immunopathology and Pharmacology
2005; 18: 531–539.
Freydiere, AM, Guinet, R, Boiron, P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Medical Mycology
2001; 39: 9–33.
Boyton, R, Openshaw, PJ. Pulmonary defences to acute respiratory infections. British Medical Bulletin
2002; 61: 1–12.
. New England Journal of Medicine
2009; 360: 1870–1884.
Kullberg, BK, Arendrup, M. Invasive candidiasis. New England Journal of Medicine
2015; 373: 1445–1456.
Birrenbachm, T, et al.
Emergence of Blastoschizomyces capitatus yeast infections, Central Europe. Emerging Infectious Diseases
2012; 18: 98–101.
Garcia-Solache, MD, Casadevall, A. Global warming will bring new fungal diseases for mammals. MBio
2010; 1: 1–3.
Nedret Koc, A, et al.
Molecular epidemiology and antifungal susceptibility of Saprochaete capitata (Blastoschizomyces capitatus) isolates causing nosocomial infection in Kayseri/Turkey. Infectious Diseases (London, England)
2016; 48: 596–603.
Sancak, B, et al.
Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods. Mikrobiyoloji Bulteni
2009; 43: 269–276.
Chittick, P, et al.
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micofungin therapy. Antimicrobial Agents and Chemotherapy
2009; 53: 5306–5307.
Desnos-Ollivier, M, et al.
Misidentification of Saprochaete clavata as Magnusiomyces capitatus in clinical isolates: utility of internal transcribed spacer sequencing and matrix-assisted laser desorption ionization–time of flight mass spectrometry and importance of reliable databases. Journal of Clinical Microbiology
2014; 52: 2196–2198.